当前位置:首页 - 行情中心 - 华纳药厂(688799) - 财务分析 - 现金流量表

华纳药厂

(688799)

  

流通市值:83.98亿  总市值:83.98亿
流通股本:1.31亿   总股本:1.31亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金655,607,002.27320,048,769.151,189,177,196.01949,522,746.23
  收到的税费返还232,901.61209,973.9171,372.04105,001.65
  收到其他与经营活动有关的现金26,518,671.579,981,470.13105,840,198.4645,232,534.51
  经营活动现金流入小计682,358,575.45330,240,213.181,295,188,766.51994,860,282.39
  购买商品、接受劳务支付的现金91,007,867.7442,945,373.34134,137,661.5173,991,736.92
  支付给职工以及为职工支付的现金101,190,699.456,133,602.47170,121,903.79131,021,748.32
  支付的各项税费80,888,184.5628,279,462.06198,708,948.2148,278,479.98
  支付其他与经营活动有关的现金327,194,821.91161,363,765.75649,994,825.41579,904,091.07
  经营活动现金流出小计600,281,573.61288,722,203.621,152,963,338.91933,196,056.29
  经营活动产生的现金流量净额82,077,001.8441,518,009.56142,225,427.661,664,226.1
二、投资活动产生的现金流量:
  收回投资收到的现金403,000,000183,000,000240,535,044.1695,000,000
  取得投资收益收到的现金2,782,019.761,914,997.31235,959.293,509.88
  处置固定资产、无形资产和其他长期资产收回的现金净额--23,030.984,300
  投资活动现金流入小计405,782,019.76184,914,997.31240,794,034.3495,097,809.88
  购建固定资产、无形资产和其他长期资产支付的现金214,144,284.4499,249,847.48233,870,746.05111,439,140.31
  投资支付的现金339,700,000210,199,600365,741,500382,741,500
  投资活动现金流出小计553,844,284.44309,449,447.48599,612,246.05494,180,640.31
  投资活动产生的现金流量净额-148,062,264.68-124,534,450.17-358,818,211.71-399,082,830.43
三、筹资活动产生的现金流量:
  吸收投资收到的现金9,974,4939,974,493--
  其中:子公司吸收少数股东投资收到的现金9,974,4939,974,493--
  取得借款收到的现金121,744,764.5220,532,856100,612,445.7673,703,508
  收到其他与筹资活动有关的现金---1,116,670.84
  筹资活动现金流入小计131,719,257.5230,507,349100,612,445.7674,820,178.84
  分配股利、利润或偿付利息支付的现金57,931,865.76672,529.8786,348,949.21,254,928.85
  筹资活动现金流出小计57,931,865.76672,529.8786,348,949.21,254,928.85
  筹资活动产生的现金流量净额73,787,391.7629,834,819.1314,263,496.5673,565,249.99
四、汇率变动对现金及现金等价物的影响-145,063.05-45,415.63424,097.99-338,054.94
五、现金及现金等价物净增加额7,657,065.87-53,227,037.11-201,905,189.56-264,191,409.28
  加:期初现金及现金等价物余额175,439,940.58175,439,940.58377,345,130.14377,345,130.14
  期末现金及现金等价物余额183,097,006.45122,212,903.47175,439,940.58113,153,720.86
补充资料:
  净利润62,119,334.13-138,760,474.32-
  资产减值准备1,394,445.07-11,114,286.28-
  固定资产和投资性房地产折旧32,875,639.8-64,857,672.32-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧32,875,639.8-64,857,672.32-
  无形资产摊销3,586,552.5-4,455,192.56-
  长期待摊费用摊销3,050,870.48-2,805,282.26-
  固定资产报废损失36,424.9-30,600.76-
  财务费用-145,063.05--11,054,777.1-
  投资损失3,181,624.95-18,511,764.58-
  递延所得税7,540,844.58--21,054,967.56-
  其中:递延所得税资产减少7,564,947.11--21,079,070.09-
    递延所得税负债增加-24,102.53-24,102.53-
  存货的减少-3,022,808.28--55,232,047.78-
  经营性应收项目的减少-31,175,838.5--118,653,622.62-
  经营性应付项目的增加1,886,707.06-106,392,099.65-
  现金的期末余额183,097,006.45-175,439,940.58-
  减:现金的期初余额175,439,940.58-377,345,130.14-
  现金及现金等价物的净增加额7,657,065.87--201,905,189.56-
公告日期2025-08-302025-04-222025-04-222024-10-29
审计意见(境内)标准无保留意见
TOP↑